Literature DB >> 20837811

Pilot study of levodopa dose as treatment for residual amblyopia in children aged 8 years to younger than 18 years.

Michael X Repka, Raymond T Kraker, Roy W Beck, C Scott Atkinson, Darron A Bacal, Don L Bremer, Patricia L Davis, Matthew D Gearinger, Stephen R Glaser, Darren L Hoover, Daniel M Laby, David G Morrison, David L Rogers, Nicholas A Sala, Donny W Suh, Maynard B Wheeler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20837811      PMCID： PMC3137458          DOI： 10.1001/archophthalmol.2010.178

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  9 in total

1.  Occlusion and levodopa-carbidopa treatment for childhood amblyopia.

Authors:  L E Leguire; G L Rogers; P D Walson; D L Bremer; M L McGregor
Journal:  J AAPOS       Date:  1998-10       Impact factor: 1.220

2.  The effect of increasing doses of levodopa on children with strabismic amblyopia.

Authors:  E Procianoy; F D Fuchs; L Procianoy; F Procianoy
Journal:  J AAPOS       Date:  1999-12       Impact factor: 1.220

3.  Visual acuities and scotomas after 3 weeks' levodopa administration in adult amblyopia.

Authors:  I Gottlob; S S Wizov; R D Reinecke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

4.  A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

Authors:  Roy W Beck; Pamela S Moke; Andrew H Turpin; Frederick L Ferris; John Paul SanGiovanni; Chris A Johnson; Eileen E Birch; Danielle L Chandler; Terry A Cox; R Clifford Blair; Raymond T Kraker
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

5.  Levodopa-carbidopa with occlusion in older children with amblyopia.

Authors:  Prashant Bhartiya; Pradeep Sharma; Nihar R Biswas; Radhika Tandon; Sudarshan K Khokhar
Journal:  J AAPOS       Date:  2002-12       Impact factor: 1.220

6.  Visual acuities after levodopa administration in amblyopia.

Authors:  K Mohan; V Dhankar; A Sharma
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2001 Mar-Apr       Impact factor: 1.402

7.  Longitudinal study of levodopa/carbidopa for childhood amblyopia.

Authors:  L E Leguire; P D Walson; G L Rogers; D L Bremer; M L McGregor
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1993 Nov-Dec       Impact factor: 1.402

8.  Long-term follow-up of L-dopa treatment in children with amblyopia.

Authors:  Lawrence E Leguire; Kelly L Komaromy; Theresa M Nairus; Gary L Rogers
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2002 Nov-Dec       Impact factor: 1.402

9.  Levodopa/carbidopa treatment for amblyopia in older children.

Authors:  L E Leguire; P D Walson; G L Rogers; D L Bremer; M L McGregor
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1995 May-Jun       Impact factor: 1.402
  9 in total
  14 in total

1.  Efficiency of the occlusion therapy with and without levodopa-carbidopa in amblyopic children-A tertiary care centre experience.

Authors:  Ishfaq Ahmad Sofi; Satish K Gupta; Anuradha Bharti; Tariq G Tantry
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

Review 2.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

3.  Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy.

Authors:  Deanna P Lyttle; Lenworth N Johnson; Edward A Margolin; Richard W Madsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-20       Impact factor: 3.117

Review 4.  Occlusion for stimulus deprivation amblyopia.

Authors:  Aileen Antonio-Santos; Satyanarayana S Vedula; Sarah R Hatt; Christine Powell
Journal:  Cochrane Database Syst Rev       Date:  2014-02-06

Review 5.  Dopamine signaling and myopia development: What are the key challenges.

Authors:  Xiangtian Zhou; Machelle T Pardue; P Michael Iuvone; Jia Qu
Journal:  Prog Retin Eye Res       Date:  2017-06-07       Impact factor: 21.198

6.  A randomized trial of levodopa as treatment for residual amblyopia in older children.

Authors:  Michael X Repka; Raymond T Kraker; Trevano W Dean; Roy W Beck; R Michael Siatkowski; Jonathan M Holmes; Cynthia L Beauchamp; Richard P Golden; Aaron M Miller; Lisa C Verderber; David K Wallace
Journal:  Ophthalmology       Date:  2015-02-09       Impact factor: 12.079

Review 7.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

Review 8.  An update on pharmacological treatment options for amblyopia.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Carlo Enrico Traverso
Journal:  Int Ophthalmol       Date:  2020-08-07       Impact factor: 2.031

9.  Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial.

Authors:  C Gail Summers; John E Connett; Ann M Holleschau; Jennifer L Anderson; Inge De Becker; Brian S McKay; Murray H Brilliant
Journal:  Clin Exp Ophthalmol       Date:  2014-05-05       Impact factor: 4.207

10.  Occlusion-amblyopia following high dose oral levodopa combined with part time patching.

Authors:  Mihir Kothari
Journal:  Indian J Ophthalmol       Date:  2014-12       Impact factor: 1.848
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.